2 / 7
Page 17
Notes:
allied
academies
August 27-28, 2018 | London, UK
International Conference on
Healthcare and Health Management
Cardiology and Cardiac Surgery
Joint Event
&
Journal of Public Health Policy and Planning | Volume: 2
Thermobalancing therapy as the first-line treatment enables effective and safe chronic disease
management at home and can reduce Healthcare costs Internationally
Simon Allen
Fine Treatment, UK
Objective:
Elderly people usually live with one or more chronic
diseases. A person after 67 without a chronic illness has a
chance to live 22 years longer than people with a chronic
condition. Thermobalancing therapy (TT) with Dr Allen’s
therapeutic Devices (DATD) provide effective care for various
chronic diseases, therefore, they are important tools to extend
the healthy life of people.
Methods:
The use of TT and DATD has been studied in adults
with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS),
kidney stone disease and benign prostatic hyperplasia (BPH).
The empirical evidence has been gathered for about 10 years
in people with these chronic non-malignant conditions. Two
clinical trials observed the dynamics of clinical characteristics
and parameters, such as symptoms, quality of life (QoL) and
ultrasound prostate volume (PV) before and after use of TT
with DATD. These results were compared with men in the no-
treatment control groups. 124 men with BPH and 45 men with
CP/CPPS used DATD for 6-month period, as mono-therapy.
Results:
Empirical data 4 people with kidney stone disease
who were selected from the total number of observations for
10 years showed that after using DATD, the kidney stones were
dissolved without side effects. The outcomes of clinical trials
confirmed TT with DATD has diminished PV in men with CP/
CPPS from 45mL to 31mL and in men BPH from 31mL to 27mL;
symptoms and QoL improved significantly in both treatment
groups, while in the control groups there were no positive
changes.
Conclusions:
Kidney stone disease, CP/CPPS and BPH are
common problems affecting 30% of population. Management
of chronic non-malignant prostate and kidney diseases using
TT with DATD creates an opportunity for people with such
conditions to remain healthier with aging. TT enables effective
and safe chronic disease management at home and can reduce
healthcare costs internationally.
Speaker Biography
Simon Allen is a highly experienced medical professional, with over 45 years of
work experience in clinical medicine. He obtained a PhD in Medicine in 1978. For
over 14 years, he worked at and subsequently headed a hospital’s cardio-vascular
department, and treated patients with renal diseases. At the age of 33 he had
authored more than 50 scientific articles on metabolic disorders, including those
linked to obesity, kidneys, arthritis, cardio-vascular and gastroenterological diseases.
He lectured medical doctors pursuing higher medical qualifications. He then devoted
nearly two decades to further medical research into various chronic diseases. He
is the author of The Origin of Diseases Theory and the inventor of the effective
devices which enable the Thermobalancing therapy. He is a member of the ATA.
e:
finetreatment@gmail.com